GNMSF - Genmab A/S (GMAB) CEO Jan van de Winkel on Q1 2022 Results - Earning Call Transcript

Genmab A/S (GMAB) Q1 2022 Earning Conference Call May 11, 2022 12:00 PM ET Company Participants Jan van de Winkel - President and Chief Executive Officer Anthony Pagano - Chief Financial Officer Conference Call Participants Peter Virgil - Citigroup James Gordon - JPMorgan Wimal Kapadia - Bernstein Peter Welford - Jefferies Michael Schmidt - Guggenheim Securities Asthika Goonewardene - Truist Securities Xian Deng - Berenberg Charlie Yang - Morgan Stanley Yaron Werber - Cowen & Co. Presentation Operator Hello, and welcome to the Genmab Q1 2022 Conference Call. Throughout the call, all participants will be in listen only mode. And afterwards, there will be a question-and-answer session. Just to remind you, this conference call is being recorded. During the telephone conference, you may be presented with forward-looking statements that include words such as believes, anticipates, plans or expects. Actual results may differ materially. For example, as a result of delayed

For further details see:

Genmab A/S (GMAB) CEO Jan van de Winkel on Q1 2022 Results - Earning Call Transcript